Skip to main content

Table 1 Demographics of the participants whose data were analysed in March 2019

From: Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

Number of people

891

Sex (Women, %)

75.5%

Age (mean ± SD, years)

86.15 ± 7.89

Nursing care levela (nursing care level > 2, %)

37.5%

EQ-5D-5L scores (mean ± SD)

0.63 ± 0.25

BI scores (mean ± SD)

61.9 ± 32.8

MMSE scores (mean ± SD)

17.0 ± 8.8

DBD scores (mean ± SD)

16.2 ± 13.8

VI scores (mean ± SD)

7.5 ± 2.6

Daily medication costs (mean ± SD, JPY/day)

507.1 ± 629.6

Number of medications (mean ± SD)

7.1 ± 3.7

Concomitant drugs (Usage, %)

 Antidiabetic

11.7%

 Antihypertensive

16.0%

 Antihyperlipidaemic

38.8%

 Antiulcer

47.6%

 Vasodilator

44.7%

 Antacid

44.1%

  1. SD standard deviation; EQ-5D-5L EuroQoL-5D-5L-proxy, BI Barthel Index, MMSE Mini-Mental State Examination, DBD Dementia Behaviour Disturbance Scale, VI Vitality Index
  2. a The degree of care needed in Japan is divided into seven categories: two “support needed” levels plus five “nursing care” levels. The type of care services provided under a long-term care insurance scheme in Japan is determined based on these categories